Mechanisms of Fuling Zexie decoction against metabolic dysfunction-associated steatotic liver disease: Integrative metabolomics, gut microbiota and serum pharmacochemistry

doi:10.3748/wjg.123034

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 33, Issue 1

This Article

(5)

(6)

(0)

(370)

Peer-Review Report of This Article

Supplementary Materials of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Study

Copyright: ©Author(s) 2027. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See permissions. Published by Baishideng Publishing Group Inc.

World J Gastroenterol. Jan 7, 2027; 33(1): 123034
Published online Jan 7, 2027. doi: 10.3748/wjg.123034

Full Size Figure Download Figure

Figure 6 Integrated analysis of Fuling Zexie decoction-derived compounds and metabolomics. A: Venn diagram of Fuling Zexie decoction (FZD)-derived compound targets and metabolic dysfunction-associated steatotic liver disease (MASLD) targets; B: Venn diagram of anti-MASLD targets of FZD-derived compounds and FZD-regulated metabolic pathway targets; C: The “active compound-target-pathway-metabolite” network; D: Molecular docking between key components and core targets. FZD: Fuling Zexie decoction group; MASLD: Metabolic dysfunction-associated steatotic liver disease.

Citation: Wang PQ, Yang H, Tang YM, Tao YX, Han SC, Zhou QD, Yu J, Yang XX. Mechanisms of Fuling Zexie decoction against metabolic dysfunction-associated steatotic liver disease: Integrative metabolomics, gut microbiota and serum pharmacochemistry. World J Gastroenterol 2027; 33(1): 123034
URL: https://www.wjgnet.com/1007-9327/full/v33/i1/123034.htm
DOI: https://dx.doi.org/10.3748/wjg.123034

Wang PQ, Yang H, Tang YM, Tao YX, Han SC, Zhou QD, Yu J, Yang XX. Mechanisms of Fuling Zexie decoction against metabolic dysfunction-associated steatotic liver disease: Integrative metabolomics, gut microbiota and serum pharmacochemistry. World J Gastroenterol 2027; 33(1): 123034 [DOI: 10.3748/wjg.123034]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.